Krystal Biotech, Inc. (KRYS)
KRYS price $325.37 +3.19 +0.99%
- Ticker
- KRYS
- Price
- $325.37
- Change
- +3.19 +0.99%
- Market cap
- $9.63B
- P/E
- 38.96
- Forward P/E
- 43.96
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 58
Krystal Biotech, Inc. is a clinical-stage biotechnology company focused on developing redosable gene therapies to address severe orphan diseases across the United States. Its most advanced therapeutic candidate, beremagene geperpavec (B-VEC), is currently undergoing Phase III clinical evaluation for the treatment of dystrophic epidermolysis bullosa. The company's pipeline also includes several other promising…